M. Chartier
M. Chartier publishes mostly in Oncology, Economics and Econometrics and Nephrology, on topics such as Cancer Immunotherapy and Biomarkers, Health Systems, Economic Evaluations, Quality of Life and Economic and Financial Impacts of Cancer.
- World rank
- #1,548,853 of 1,633,909 ranked researchers
- Rank in France
- #92,008 of 96,116
- Works
- 15
- Citations
- 5
- Citations per work
- 0.3
What does M. Chartier research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Oncology21% of their works
- 2Economics and Econometrics21% of their works
- 3Nephrology12% of their works
- 4Rheumatology8% of their works
- 5Immunology4% of their works
- 6Genetics4% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Diabetes and associated disorders
- Immunodeficiency and Autoimmune Disorders
- Atrial Fibrillation Management and Outcomes
- Chronic Lymphocytic Leukemia Research
- Platelet Disorders and Treatments
Which keywords describe M. Chartier's research?
The keywords of their largest research topics: Cost of Care, Cost-effectiveness Analysis, Financial Toxicity, Immune Checkpoint Blockade, PD-1 and PD-L1, Quality of Life, Anticoagulant Therapy and Atrial Fibrillation.
- Type 1 Diabetes
- Primary Immunodeficiency
- Genomic Aberrations
- Genetic Mutations
- Atrial Fibrillation
- Quality of Life
- Immune Checkpoint Blockade
- Cost-effectiveness Analysis
- Cost of Care
- Financial Toxicity
- PD-1 and PD-L1
- Anticoagulant Therapy
- Chronic Lymphocytic Leukemia
- Genetics
- Platelets
- Thrombosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost of Care21 topic
- Cost-effectiveness Analysis21 topic
- Financial Toxicity21 topic
- Immune Checkpoint Blockade21 topic
- PD-1 and PD-L121 topic
- Quality of Life21 topic
- Anticoagulant Therapy11 topic
- Atrial Fibrillation11 topic
- Chronic Lymphocytic Leukemia11 topic
- Genetic Mutations11 topic
- Genetics11 topic
- Genomic Aberrations11 topic
- Platelets11 topic
- Primary Immunodeficiency11 topic
- Thrombosis11 topic
- Type 1 Diabetes11 topic
Where does M. Chartier work?
M. Chartier's main affiliation in the publication record is Bristol-Myers Squibb (France), France.
How many publications and citations does M. Chartier have?
Science Explorer counts 15 works and 5 citations for M. Chartier, ranking #1,548,853 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named M. Chartier
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.